CHICKEN POX-VARICELLA

Chickenpox, medically known as varicella, is a highly contagious viral infection caused by the varicella-zoster virus (VZV), a member of the herpesvirus family. It predominantly affects children but can also pose significant health risks in adults, pregnant women, and immunocompromised individuals. The disease is primarily transmitted through respiratory droplets and direct contact with vesicular fluid, and is characterized by an itchy, blistering rash, often accompanied by fever, fatigue, and malaise. While most cases are self-limiting and resolve within 7–10 days, complications such as bacterial superinfection, pneumonia, encephalitis, and congenital varicella syndrome can occur, especially in high-risk groups.The introduction of the varicella vaccine has drastically reduced the global burden of chickenpox, especially in countries with high immunization coverage. Vaccination not only protects individuals from the disease but also contributes to herd immunity, preventing outbreaks and transmission in communities. Despite these advances, breakthrough infections, vaccine hesitancy, and limited access to healthcare in low-resource settings continue to challenge control efforts.Diagnosis is often made clinically due to the disease's characteristic presentation, but laboratory confirmation through PCR or serologic tests may be required in atypical or severe cases. Management is typically supportive, with antiviral therapy reserved for at-risk individuals or severe disease. Isolation during the infectious period is critical to prevent further transmission, particularly in institutional or healthcare settings.In addition to acute infection, VZV remains latent in sensory ganglia and can reactivate later in life as herpes zoster (shingles), adding to the long-term burden of the virus. Thus, lifelong immunity, booster vaccination, and zoster vaccination in older adults are important aspects of comprehensive varicella control strategies.This article provides a comprehensive review of chickenpox, including its epidemiology, virology, pathogenesis, clinical features, diagnosis, complications, treatment, prevention, and public health impact. Through increased awareness, effective vaccination strategies, and robust public health policies, chickenpox can be further controlled and its complications minimized globally.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-08
DOI
https://doi.org/10.5281/zenodo.15176789
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CHICKEN POX-VARICELLA

Zenodo (CERN European Organization for Nuclear Research)
Herpesvirus Infections and Treatments
article

CHICKEN POX-VARICELLA

article en

Abstract

Chickenpox, medically known as varicella, is a highly contagious viral infection caused by the varicella-zoster virus (VZV), a member of the herpesvirus family. It predominantly affects children but can also pose significant health risks in adults, pregnant women, and immunocompromised individuals. The disease is primarily transmitted through respiratory droplets and direct contact with vesicular fluid, and is characterized by an itchy, blistering rash, often accompanied by fever, fatigue, and malaise. While most cases are self-limiting and resolve within 7–10 days, complications such as bacterial superinfection, pneumonia, encephalitis, and congenital varicella syndrome can occur, especially in high-risk groups.The introduction of the varicella vaccine has drastically reduced the global burden of chickenpox, especially in countries with high immunization coverage. Vaccination not only protects individuals from the disease but also contributes to herd immunity, preventing outbreaks and transmission in communities. Despite these advances, breakthrough infections, vaccine hesitancy, and limited access to healthcare in low-resource settings continue to challenge control efforts.Diagnosis is often made clinically due to the disease's characteristic presentation, but laboratory confirmation through PCR or serologic tests may be required in atypical or severe cases. Management is typically supportive, with antiviral therapy reserved for at-risk individuals or severe disease. Isolation during the infectious period is critical to prevent further transmission, particularly in institutional or healthcare settings.In addition to acute infection, VZV remains latent in sensory ganglia and can reactivate later in life as herpes zoster (shingles), adding to the long-term burden of the virus. Thus, lifelong immunity, booster vaccination, and zoster vaccination in older adults are important aspects of comprehensive varicella control strategies.This article provides a comprehensive review of chickenpox, including its epidemiology, virology, pathogenesis, clinical features, diagnosis, complications, treatment, prevention, and public health impact. Through increased awareness, effective vaccination strategies, and robust public health policies, chickenpox can be further controlled and its complications minimized globally.

Zenodo (CERN European Organization for Nuclear Research)
Osh State University (KG)
Openalex Percentile: Top 46%
Herpesvirus Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.